BNBernd Axel Neubauer

Bernd Axel Neubauer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bernd Axel Neubauer has a total of 228 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Enhancement of Family-Centred Care Is Associated with a Reduction in Postmenstrual Age at Discharge in Preterm Infants

    by Rahel Schuler, Carola Eiben, Markus Waitz, Bernd A. Neubauer, Andreas Hahn, Walter A. Mihatsch

    Background/Objectives: Long hospitalisation has been recognized as an independent risk factor for poor neurodevelopmental outcomes of preterm infants. Systematic training and early inclusion of parents in their preterm infant’s care is a strategy to shorten the length of hospital stay. We implemented an enhanced stepwise family-centred care program and assessed its effects on postmenstrual age (PMA) at discharge and parental satisfaction. Methods: This prospective single-centre longitudinal cohort study was carried out in a German level III neonatal unit from October 2020 to May 2023. Five consecutive 6-month cohorts (1 baseline and 4 intervention cohorts, 169 infants and their caregivers) were analysed. Results: Mean PMA at discharge did not change in the total cohort but declined significantly in patients without neonatal morbidities from baseline to cohort 4 (37.2 ± 1.4 to 36.1 ± 1.6 weeks; p = 0.036). Concomitantly, discharge with tube feeding raised from 2.4% to 74.1% (p < 0.001) and discharge with home monitoring raised from 9.8% to 74.1% (p < 0.001), while unplanned readmissions remained unchanged (p = 0.44). Parental satisfaction with time point of discharge increased non-significantly from baseline to cohort 4 (75.8% vs. 95.7%; Chi2 0.22). Conclusions: Discharge of preterm infants at a significantly lower PMA is feasible through enhancement of family-centred care and is very well accepted by parents.


  • Open Access

    Implementation and Assessment of a Laparotomy-Assisted Three-Port Fetoscopic Spina Bifida Repair Program

    by Corinna Keil, Siegmund Köhler, Benjamin Sass, Maximilian Schulze, Gerald Kalmus, Michael Belfort, Nicolas Schmitt, Daniele Diehl, Alice King, Stefanie Groß, et al.

    Open spina bifida (OSB) is a congenital, non-lethal malformation with multifactorial etiology. Fetal therapy can be offered under certain conditions to parents after accurate prenatal diagnostic and interdisciplinary counseling. Since the advent of prenatal OSB surgery, various modifications of the original surgical techniques have evolved, including laparotomy-assisted fetoscopic repair. After a two-year preparation time, the team at the University of Giessen and Marburg (UKGM) became the first center to provide a three-port, three-layer fetoscopic repair of OSB via a laparotomy-assisted approach in the German-speaking area. We point out that under the guidance of experienced centers and by intensive multidisciplinary preparation and training, a previously described and applied technique could be transferred to a different setting.


  • Open Access

    Noninvasive Ventilation and Rapid Enteral Feeding Advances in Preterm Infants—2-Year Follow-Up of the STENA-Cohort

    by Judith Behnke, Vanessa Estreich, Frank Oehmke, Bernd Axel Neubauer, Anita Windhorst, Harald Ehrhardt

    The importance of nutritional supply for somatic growth and neurodevelopmental outcome in very-low-birthweight infants is an established medical strategy for reducing long-term morbidities. Our cohort study on rapid enteral feeding advances using a standardized protocol (STENA) previously demonstrated a 4-day reduction of parenteral nutrition. STENA did not impede the success of noninvasive ventilations strategies but significantly less infants required mechanical ventilation. Most importantly, STENA resulted in improved somatic growth at 36 weeks of gestation. Here, we evaluated our cohort for psychomotor outcomes and somatic growth at 2 years of age. n = 218 infants of the original cohort were followed-up (74.4%). Z-scores for weight and length did not differ but the benefits of STENA for head circumference persisted until the age of 2 years (p = 0.034). Concerning the psychomotor outcome, we neither found any statistically significant differences in the mental developmental index (MDI) (p = 0.738), norin the psychomotor developmental index (PDI) (p = 0.122). In conclusion, our data adds important insights on the topic of rapid enteral feeding advances and confirms the safety of STENA with respect to somatic growth and psychomotor outcome measures.


  • Intrauterine Fetoscopic Repair of Myelomeningocele: 30-Month Follow-up Data

    by Bernd A. Neubauer, Danielle Diehl

    Background: The MOMS trial demonstrated that intrauterine open repair of MMC after hysterotomy results in marked improvement of motor and mental milestones and greatly reduces VP-shunt placement. A less invasive procedure is resembled by a total percutaneous intrauterine fetoscopic repair, which reduces risks like uterus rupture and enables transvaginal deliveries in subsequent pregnancies. Methods: From 2010 to 2014, a group of 72 children received percutaneous intrauterine repair of MMC in Giessen. 52 (72%) were reinvestigated up to 30 months after the procedure. Mortality data are available for all operated children. Included children were assessed at four time points: (1) directly after birth, (2) at age 3 months, (3) at age 12 months, and (4) 30 months of corrected age. Results: All children survived the intrauterine procedure. However, postnatally four children (5.5%) died. 11.7% were born before the 30th gestational week. Shunt placement took place in 48% of the intrauterine operated children. Free ambulation without assistance was possible for 46% at the age of 30 months. Bayley scales exceeding 70% were reached by 70% of children for MDI and 80% for BDI. Conclusion: Considering mortality, gross motor function, mental scores and VP-Shunt rate, intrauterine repair by fetoscopy or open repair (MOMS trial) results in a comparable outcome. Results of our study are restricted by its retrospective nature. Additionally, in our fetoscopic study only children with at least partially retained leg movement were included. This was not a necessary inclusion criterion in the moth trial. Publication Date: 28 October 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Epilepsy in Neuropediatrics

    by Bernd A. Neubauer

    In this issue, epilepsy is not the exclusive, but a dominant topic. This justifies an editorial focus on the included articles. Samanta[1] gives a narrative review on advances in diagnosis and treatment of neonatal seizures. Neonatal seizures are a worrisome clinical sign for pediatric neurologists and neonatologists alike. Moreover, the substantial threat of acute and chronic encephalopathy is an emotional disaster for parents and caregivers. An orderly approach to a diagnostic workup is pertinent, because in many cases clarification of the underlying etiology will take time. Genetic, metabolic, and infectious causes are extremely diverse, which leave the treating physician always with a significant amount of insecurity if no cause is readily detected, since some of these causes are amendable by a specific treatment. All these topics are nicely covered in an easy to read and up to date review. Samanta[1] covers clinical signs, seizure semiology, and neonatal electroencephalography (EEG). A comparison of studies reporting on differing sensitivity and specificity of conventional versus amplitude integrated EEG is also given. New randomized controlled trials (NEMO and NEOLEV2) are included in a proposed treatment algorithm for neonatal seizures. Finally, it is emphasized that in “idiopathic” neonatal seizures, a genetic cause may be detectable in up to 30% of cases. In some cases, these results will open a possibility of precision medicine (e.g., sodium channel blockers in KCNQ2-related epileptic encephalopathy), while in many other instances, they only relieve the clinician by providing certainty that “nothing was missed.” An interesting paper on risk factors for mortality among newborns with neonatal seizures is provided by Tanous et al[2] in this issue. This topic is difficult to investigate in a controlled fashion. There is only one prospective trial published, namely, by Glass et al.[3] This, together with other less well-controlled series, is used as a comparator for the retrospective study by Tanous et al.[2] The study was performed in a large cohort with a mix of two ethnically distinct populations in the northeast of Israel: one group featuring a high rate of consanguinity and one with an average rate. In this large retrospective single hospital series, 1.7 per 1000 live births developed neonatal seizures, with hypoxic ischemic encephalopathy as the most frequent cause. However, almost 30% of infants with neonatal seizures died in the first year, a number that is twice as large as in other reports. The authors show that in their series children with congenital brain malformations and other monogenetic disorders were overrepresented in the group with fatal outcome. The reported numbers exceed findings reported by Glass et al, but are in line with other publications specifically reporting on highly consanguineous populations. The paper by Willimsky et al[4] investigates sensitivity and specificity of next generation sequencing for monogenetic epilepsies and developmental and epileptic encephalopathies (DEE). Larger gene panels covering >25 kb are (of course) more sensitive than those <25 kb, but at the same time more results of unknown significance will be generated by the larger panels. The included number of patients in this study is rather modest (n = 190) and mode of analysis is technically heterogeneous. The authors divide their sample into patients with epilepsy only (non-DEE) and patients with DEE. In both samples, the detection rate increased when larger panels were compared with smaller ones. However, in the non-DEE group, this effect was clearly more pronounced and reached statistical significance. While this may also be partly attributable to differing sizes of both groups, the authors argue that in non-DEE patients, the increase in detection rate by larger gene panels is greater than in DEE patients, because in patients with DEE the gene candidates are fewer and better defined. Therefore, in a scenario of financial restrictions using a larger gene panel may be more cost efficient in non-DEE patients in a first-step approach of genetic workup. Virtually as an exemplification of the article by Willimsky et al,[4] Algahtani et al[5] report on a new homozygous variant in HERGC2 in a consanguine Arab family. Three affected siblings in this family suffer from a severe DEE. HERC2 mutations were recently detected among Old Order Amish families (MIM #605837). The phenotype was initially described as an autosomal recessive developmental encephalopathy with similarities to Angelman syndrome. Only a few cases have been reported since its first description. The clinical spectrum is best characterized by a severe mental handicap with autistic features, with or without epilepsy. It is one those rare genes that will currently not be included in any (epilepsy) gene panel no matter how large. Febrile infection-related epilepsy syndrome (FIRES) is probably the most malignant epileptic encephalopathy of childhood. A significant number of children with FIRES have died, while others have remained on intensive care for almost a year. The sudden onset of this irreversible “gray matter failure” resembles the most striking and most unparalleled feature of FIRES. There are only very few cases of children surviving FIRES without severe sequelae. Many suffer from continuous therapy resistant epilepsy. In 2011, Kramer et al[6] published a series of 77 children reporting the apparently positive results of high-dose phenobarbital, benzodiazepines, and ketogenic diet in controlling status epilepticus. In this issue, Baba et al[7] support this view and report on a girl who was treated with high-dose thiamylal (unavailable in Europe, closely related to thiopental) combined with parenteral ketogenic diet starting at day 6. Steroids, immunoglobulins, and benzodiazepines were also applied. The course of treatment in the intensive care unit was complicated;...


  • Epilepsien

    by Bernd A. Neubauer, Thomas Bast

  • Open Access

    Fully percutaneous fetoscopic repair of myelomeningocele: 30‐month follow‐up data

    by D. Diehl, F. Belke, T. Kohl, R. Axt‐Fliedner, J. Degenhardt, A. Khaleeva, Frank Öehmke, D. Faas, H. Ehrhardt, M. Kolodziej, et al.

    Objective: This observational study reports on the postnatal mortality and 30‐month outcome of children who underwent fully percutaneous fetoscopic repair of myelomeningocele (MMC) at a single center in Giessen, Germany.Methods: Between October 2010 and August 2014, a total of 72 patients underwent fully percutaneous fetoscopic MMC closure at 21 + 0 to 29 + 1 (mean, 23 + 5) weeks' gestation. Of these, 52 (72%) participated in this study; however, 30‐month mortality data are available for all 72 children. Children were examined at four timepoints: shortly after birth and at 3 months, 12 months and 30 months of corrected age. The patients underwent age‐specific standardized neurological examinations and assessment of leg movements and ambulation at all timepoints. Cognitive and motor development were assessed using the Bayley Scales of Infant Development, second edition (BSID‐II), at 30 months.Results: All 72 children survived the intrauterine procedure, however, four (5.6%) infants died postnatally (including two of the 52 comprising the study cohort). Of the 52 patients included in the study, 11.5% were delivered before the 30th week of gestation (mean, 33 + 1 weeks) and, of the survivors, 48.1% had ventriculoperitoneal shunt placement. Of the 50 infants that were alive at 30 months, independent ambulation, without orthosis, was feasible for 46%. At 30 months of follow‐up, 46% of children presented with a functional level that was at least two segments better than the anatomical level of the lesion. At 30 months, 70% of the children presented with BSID‐II psychomotor development index score of ≥ 70 and 80% with BSID‐II mental development index score of ≥ 70.Conclusion: Intrauterine repair of MMC by percutaneous fetoscopy shows largely similar outcomes to those reported for open repair, with respect to mortality, prematurity, shunt‐placement rates, motor and mental development and free ambulation. © 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.